| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.027 | 0.5 |